Camurus AB (publ)
General ticker "CAMRF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.6B (TTM average)
Camurus AB (publ) follows the US Stock Market performance with the rate: 30.0%.
Estimated limits based on current volatility of 0.0%: low 64.24$, high 64.26$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [37.37$, 66.89$]
- 2025-12-31 to 2026-12-31 estimated range: [36.62$, 65.67$]
Short-term CAMRF quotes
Long-term CAMRF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK956.34MM | SEK1,716.85MM | SEK1,867.58MM |
| Operating Expenses | SEK884.38MM | SEK1,190.95MM | SEK1,398.42MM |
| Operating Income | SEK71.96MM | SEK525.90MM | SEK469.17MM |
| Non-Operating Income | SEK1.17MM | SEK23.40MM | SEK83.36MM |
| Interest Expense | SEK1.53MM | SEK1.34MM | SEK1.08MM |
| R&D Expense | SEK473.76MM | SEK637.70MM | SEK683.62MM |
| Income(Loss) | SEK73.12MM | SEK549.30MM | SEK552.52MM |
| Taxes | SEK17.57MM | SEK117.86MM | SEK124.13MM |
| Profit(Loss)* | SEK39.15MM | SEK336.98MM | SEK387.62MM |
| Stockholders Equity | SEK994.67MM | SEK1,493.00MM | SEK3,289.68MM |
| Inventory | SEK107.43MM | SEK100.95MM | SEK140.22MM |
| Assets | SEK1,305.49MM | SEK1,907.82MM | SEK3,757.01MM |
| Operating Cash Flow | SEK101.20MM | SEK606.88MM | SEK387.99MM |
| Capital expenditure | SEK1.91MM | SEK10.13MM | SEK29.37MM |
| Investing Cash Flow | SEK5.38MM | SEK-10.13MM | SEK-29.37MM |
| Financing Cash Flow | SEK43.70MM | SEK28.76MM | SEK1,300.67MM |
| Earnings Per Share** | SEK0.71 | SEK5.86 | SEK6.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.